The Institute for Research in Immunology and Cancer – Commercialization of Research (IRICoR) of the Université de Montréal announces that the company will attend the 2016 Bloom Burton & Co. Healthcare Investor Conference. This conference is being held from May 2-3, 2016 in Toronto.
For more information about Bloom Burton & Co. Healthcare Investor Conference click on the following link: 2016 Bloom Burton & Co.
In order to plan a meeting with the IRICoR representatives during the conference, please contact either Dr. Steven Klein (email@example.com)
About the Institute for Research in Immunology and Cancer – Commercialization of Research (IRICoR)
IRICoR is a not-for-profit organization whose mandate is to accelerate the discovery, development and commercialization of novel drugs that originate at Université de Montreal’s Institute for Research in Immunology and Cancer and related research units. IRICoR invests in highly innovative projects to rapidly transition them from academia to the market, while identifying the best development partners for these commercially promising projects. For more information: www.iricor.ca
Steven Klein, Ph.D., MBA
Vice-President, Business Development